Legal & General Group PLC Chembio Diagnostics, Inc. Transaction History

Legal & General Group PLC

  • $470 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 12, 2021
SELL
$2.88 - $5.64 $6,278 - $12,295
-2,180 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$3.4 - $7.97 $625 - $1,466
-184 Reduced 7.78%
2,180 $8,000
Q3 2020

Nov 13, 2020
SELL
$3.28 - $5.93 $2,502 - $4,524
-763 Reduced 24.4%
2,364 $11,000
Q2 2020

Aug 14, 2020
BUY
$3.18 - $15.54 $9,943 - $48,593
3,127 New
3,127 $10,000

About CHEMBIO DIAGNOSTICS, INC.

CEMI Quotes by TradingView
  • Ticker CEMI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,224,600
  • Description
  • Chembio Diagnostics, Inc., together with its subsidiaries, develops, manufactures, and commercializes point-of-care (POC) diagnostic tests that are used to detect or diagnose diseases. The company offers tests for COVID-19, HIV and Syphilis, and Zika virus. It also develops tests for malaria, dengue, chikungunya, Chagas, ebola, leishmaniasis, la...
More about CEMI
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email